Immunodepletion of high-abundant proteins from acute and chronic wound fluids to elucidate low-abundant regulators in wound healing

BackgroundThe process of wound healing consists of several well distinguishable and finely tuned phases. For most of these phases specific proteins have been characterized, although the underlying mechanisms of regulation are not yet fully understood. It is an open question as to whether deficits in wound healing can be traced back to chronic illnesses such as diabetes mellitus. Previous research efforts in this field focus largely on a restricted set of marker proteins due to the limitations detection by antibodies imposes. For mechanistic purposes the elucidation of differences in acute and chronic wounds can be addressed by a less restricted proteome study. Mass spectrometric (MS) methods, e.g. multi dimensional protein identification technology (MudPIT), are well suitable for this complex theme of interest. The human wound fluid proteome is extremely complex, as is human plasma. Therefore, high-abundant proteins often mask the mass spectrometric detection of lower-abundant ones, which makes a depletion step of such predominant proteins inevitable.FindingsIn this study a commercially available immunodepletion kit was evaluated for the detection of low-abundant proteins from wound fluids. The dynamic range of the entire workflow was significantly increased to 5-6 orders of magnitude, which makes low-abundant regulatory proteins involved in wound healing accessible for MS detection.ConclusionThe depletion of abundant proteins is absolutely necessary in order to analyze highly complex protein mixtures such as wound fluids using mass spectrometry. For this the used immunodepletion kit is a first but important step in order to represent the entire dynamic range of highly complex protein mixtures in the future.

[1]  Michael K. Coleman,et al.  Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. , 2005, Analytical chemistry.

[2]  J. Yates,et al.  Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.

[3]  E. Eriksson,et al.  Growth Factors in the Repair of Partial Thickness Porcine Skin Wounds , 1997, Plastic and reconstructive surgery.

[4]  M. Luster,et al.  Impaired cutaneous wound healing in interleukin‐6‐deficient and immunosuppressed mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  L. Nifong,et al.  Effect of Vacuum Assisted Closure® Therapy on early systemic cytokine levels in a swine model , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[6]  V. Nube,et al.  Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers , 2009, Diabetes Care.

[7]  J. Yates,et al.  An automated multidimensional protein identification technology for shotgun proteomics. , 2001, Analytical chemistry.

[8]  G R Tobin,et al.  Physiology and healing dynamics of chronic cutaneous wounds. , 1998, American journal of surgery.

[9]  Ronald J. Moore,et al.  Toward a Human Blood Serum Proteome , 2002, Molecular & Cellular Proteomics.

[10]  L. Gould,et al.  Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[11]  David T. Kaleta,et al.  Enhanced Detection of Low Abundance Human Plasma Proteins Using a Tandem IgY12-SuperMix Immunoaffinity Separation Strategy*S , 2008, Molecular & Cellular Proteomics.

[12]  R. Kurth,et al.  Interleukin‐16 stimulates the expression and production of pro‐inflammatory cytokines by human monocytes , 2000, Immunology.

[13]  M. Korc Diabetes Mellitus in the Era of Proteomics , 2003, Molecular & Cellular Proteomics.

[14]  F. Unglaub,et al.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids. , 2010, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[15]  J. Malda,et al.  Development of an enhanced proteomic method to detect prognostic and diagnostic markers of healing in chronic wound fluid , 2007, The British journal of dermatology.

[16]  S. Halimi,et al.  Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[17]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.